Disc Medicine, Inc. (IRON)
(Delayed Data from NSDQ)
$58.03 USD
+0.96 (1.68%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $58.01 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IRON 58.03 +0.96(1.68%)
Will IRON be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IRON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRON
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy
Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's What You Should Know
IRON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Disc Medicine, Inc. (IRON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Other News for IRON
Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight
Disc Medicine (IRON) Receives a Buy from TD Cowen
Disc Medicine GAAP EPS of -$1.58
Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update | IRON ...
Disc Medicine reports Q2 EPS ($1.58), consensus ($1.14)